Does Intermittent Aortic Cross Clamping Decrease the Incidence of Atrial Fibrillation after Coronary Bypass Surgery?
AbstractAtrial fibrillation (AF) is the most common arrhythmia after coronary artery bypass grafting (CABG). AF is a vexing problem that causes morbidity, prolongs hospital stay, and increases costs. Numerous factors have been suggested to play a role in the development of AF. The aim of this study was to evaluate the effect of intermittent aortic cross clamping (IACC) compared with hypothermic cardioplegic solution (HCS) in the development of postoperative AF. We evaluated data obtained from 345 patients undergoing CABG with HCS (HCS group, n = 212) and IACC (IACC group, n = 173) between April 2004 and August 2005. Diabetes mellitus was observed more often in the HCS group (P < .05), otherwise both groups had similar preoperative characteristics including sex, age, the number of distal anastomoses, left ventricle ejection fraction, history of myocardial infarction, and use of ?-blocker medication. The only statistically significant difference between the groups was higher postoperative Ca-antagonist use in the HCS group. Rates of postoperative AF, however, were significantly lower in the IACC group (21.52%) than that in the HCS group (11.05%; P < .01). Postoperative Ca-antagonist use in the HCS group and smoking in the IACC group were independent predictors of AF after CABG. The incidence of postoperative AF after CABG with IACC was reduced compared with HCS. IACC with ventricular fibrillation may exert a counteractive effect against AF.
Abd-Elfattah AS, Ding M, Wechsler AS. 1995. Intermittent aortic crossclamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation and dysfunction (stunning): is it preconditioning? J Thorac Cardiovasc Surg110:328-39.nAd N, Snir E, Vidne BA, Golomb E. 2001. Histologic atrial myolysis is associated with atrial fibrillation after cardiac operations. Ann Thorac Surg72:688-93.nAk K, Akgun S, Tecimer T, Isbir CS, Civelek A, Tekeli A, Arsan S, Cobanoglu A. 2005. Determination of histopathologic risk factors for postoperative atrial fibrillation in cardiac surgery. Ann Thorac Surg79(6):1970-5.nAkins CW. 1987. Noncardioplegic myocardial preservation for coronary revascularisation. J Thorac Cardiovasc Surg93:261-7.nAlex J, Ansari J, Guerrero R, et al. 2003. Comparison of the immediate post-operative outcome of two different myocardial protection strategies: antegrade-retrograde cold St Thomas blood cardioplegia versus intermittent cross-clamp fibrillation. ICVTS2:584-8.nAlhan HC, Karabulut H, Tosun R, et al. 1996. Intermittent aortic cross-clamping and cold crystalloid cardioplegia for low-risk coronary patients. Ann Thorac Surg61:834-9.nAnderson JR, Hossein-Nia M, Kallis P, et al. 1994. Comparison of two strategies of myocardial management during coronary operations. Ann Thorac Surg58:768-73.nAntunes PE, Oliveria JF, Anutes MJ. 1999. Non-cardioplegic coronary surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg16(3):331-6.nAntunes PE. 2003. Coronary surgery with intermittent aortic cross-clamping: a word of caution on the incidence of cerebrovascular accidents [Letter 2]. Ann Thorac Surg76:661-2.nBonchek LI, Burlingname MW, Vazales BE, Lundy EF, Gassmann CJ. 1992. Applicability of noncardioplegic coronary bypass to high-risk patients: selection of patients, technique, and clinical experience in 3000 patients. J Thorac Cardiovasc Surg103:230-7.nCohen AS, Hadjinikolaou L, McColl A, Richmond W, Sapsford RA, Glenville BE. 1997. Lipid peroxidation, antioxidant status and troponin-T following cardiopulmonary bypass: a comparison between intermittent crossclamp with fibrillation and crystalloid cardioplegia. Eur J Cardiothorac Surg12:248-53.nCohen G, Borger MA, Weisel RD, Rao V. 1999. Interoperative myocardial protection: current trends and future perspectives. Ann Thorac Surg68:1995-2000.nCreswell LL, Schuessler RB, Rosenbloom M, Cox JL. 1993. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg56:539-49.nFujii M, Chambers DJ. 2005. Myocardial protection with intermittent-cross clamp fibrillation: does preconditioning play a role? Eur J Cardiothoracic Surg28:821-32.nFunk M, Richards SB, Desjardins J, Bebon C, Wilcox H. 2003. Incidence, timing, symptoms and risk factors for atrial fibrillation after cardiac surgery. Am J Crit Care12:424-33.nHogue CW, Hyder ML. 2000. Atrial fibrillation after cardiac operation: risks, mechanism and treatment. Ann Thorac Surg69:300-6.nMusumeci F, Feccia M, MacCarthy PA, et al. 1998. Prospective randomized trial of single clamp technique versus intermittent ischemic arrest: myocardial and neurologic outcome. Eur J Cardiothorac Surg13:702-9.nRaco L, Mills E, Milner RJ. 2002. Isolated myocardial revascularization with intermittent aortic cross-clamping: experience with 800 cases. Ann Thorac Surg73:1436-40.nTaggart DP, Bhusari S, Hooper J, et al. 1994. Intermittent ischemic arrest in coronary artery surgery: coming full circle? Br Heart J72:136-9.nVaage J. 2005. Editorial comment: old skills in a new context, but do we want to use it? Eur J Cardiothoracic Surg28:831-2.nVinten-Johansen J, Thourani VH. 2000. Myocardial protection: an overview. J Extra Corpor Technol32(1):38-48.nWeber UK, Osswald S, Huber M, et al. 1998. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo controlled study using low dose sotalol. Eur Heart J19:794-800.nYellon DM, Alkulaifi AM, Pugsley WB. 1993. Preconditioning the human myocardium. Lancet342:276-7.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).